Evaluation of Time to Onset and Outcome of Cardiac Adverse Events Associated with Nilotinib using Post-Marketing Surveillance.
Oncology
; 101(12): 799-807, 2023.
Article
in En
| MEDLINE
| ID: mdl-37598671
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pericarditis
/
Cardiac Tamponade
/
Myocardial Infarction
Type of study:
Etiology_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Humans
Language:
En
Journal:
Oncology
Year:
2023
Document type:
Article
Affiliation country: